Literature DB >> 22100336

Regulation of alternative splicing within the supraspliceosome.

Naama Sebbag-Sznajder1, Oleg Raitskin, Minna Angenitzki, Taka-Aki Sato, Joseph Sperling, Ruth Sperling.   

Abstract

Alternative splicing is a fundamental feature in regulating the eukaryotic transcriptome, as ~95% of multi-exon human Pol II transcripts are subject to this process. Regulated splicing operates through the combinatorial interplay of positive and negative regulatory signals present in the pre-mRNA, which are recognized by trans-acting factors. All these RNA and protein components are assembled in a gigantic, 21 MDa, ribonucleoprotein splicing machine - the supraspliceosome. Because most alternatively spliced mRNA isoforms vary between different cell and tissue types, the ability to perform alternative splicing is expected to be an integral part of the supraspliceosome, which constitutes the splicing machine in vivo. Here we show that both the constitutively and alternatively spliced mRNAs of the endogenous human pol II transcripts: hnRNP A/B, survival of motor neuron (SMN) and ADAR2 are predominantly found in supraspliceosomes. This finding is consistent with our observations that the splicing regulators hnRNP G as well as all phosphorylated SR proteins are predominantly associated with supraspliceosomes. We further show that changes in alternative splicing of hnRNP A/B, affected by up regulation of SRSF5 (SRp40) or by treatment with C6-ceramide, occur within supraspliceosomes. These observations support the proposed role of the supraspliceosome in splicing regulation and alternative splicing.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22100336      PMCID: PMC3298742          DOI: 10.1016/j.jsb.2011.11.005

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  51 in total

1.  Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors.

Authors:  G B ten Dam; C F Zilch; D Wallace; B Wieringa; P C Beverley; L G Poels; G R Screaton
Journal:  J Immunol       Date:  2000-05-15       Impact factor: 5.422

2.  Alternative splicing and genome complexity.

Authors:  David Brett; Heike Pospisil; Juan Valcárcel; Jens Reich; Peer Bork
Journal:  Nat Genet       Date:  2001-12-17       Impact factor: 38.330

3.  A genomic view of alternative splicing.

Authors:  Barmak Modrek; Christopher Lee
Journal:  Nat Genet       Date:  2002-01       Impact factor: 38.330

4.  Stop codons affect 5' splice site selection by surveillance of splicing.

Authors:  Binghui Li; Chaim Wachtel; Elana Miriami; Galit Yahalom; Gilgi Friedlander; Gil Sharon; Ruth Sperling; Joseph Sperling
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

5.  Cryoelectron microscopy and cryoelectron tomography of the nuclear pre-mRNA processing machine.

Authors:  Ohad Medalia; Dieter Typke; Reiner Hegerl; Mina Angenitzki; Joseph Sperling; Ruth Sperling
Journal:  J Struct Biol       Date:  2002 Apr-May       Impact factor: 2.867

6.  Large nuclear RNP particles--the nuclear pre-mRNA processing machine.

Authors:  Oleg Raitskin; Mina Angenitzki; Joseph Sperling; Ruth Sperling
Journal:  J Struct Biol       Date:  2002 Oct-Dec       Impact factor: 2.867

7.  De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1.

Authors:  Charles E Chalfant; Kristin Rathman; Ryan L Pinkerman; Rachel E Wood; Lina M Obeid; Besim Ogretmen; Yusuf A Hannun
Journal:  J Biol Chem       Date:  2002-01-18       Impact factor: 5.157

8.  FAS activation induces dephosphorylation of SR proteins; dependence on the de novo generation of ceramide and activation of protein phosphatase 1.

Authors:  C E Chalfant; B Ogretmen; S Galadari; B J Kroesen; B J Pettus; Y A Hannun
Journal:  J Biol Chem       Date:  2001-08-13       Impact factor: 5.157

9.  Alternative splicing in disease and therapy.

Authors:  Mariano A Garcia-Blanco; Andrew P Baraniak; Erika L Lasda
Journal:  Nat Biotechnol       Date:  2004-05       Impact factor: 54.908

10.  Preparation and characterization of antibodies against human ribosomal proteins: heterogeneous expression of S11 and S30 in a panel of human cancer cell lines.

Authors:  D Nadano; G Ishihara; C Aoki; T Yoshinaka; S Irie; T A Sato
Journal:  Jpn J Cancer Res       Date:  2000-08
View more
  13 in total

1.  Dual function of C/D box small nucleolar RNAs in rRNA modification and alternative pre-mRNA splicing.

Authors:  Marina Falaleeva; Amadis Pages; Zaneta Matuszek; Sana Hidmi; Lily Agranat-Tamir; Konstantin Korotkov; Yuval Nevo; Eduardo Eyras; Ruth Sperling; Stefan Stamm
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-08       Impact factor: 11.205

Review 2.  Structural studies of the endogenous spliceosome - The supraspliceosome.

Authors:  Joseph Sperling; Ruth Sperling
Journal:  Methods       Date:  2017-04-13       Impact factor: 3.608

3.  Potential for sexual conflict assessed via testosterone-mediated transcriptional changes in liver and muscle of a songbird.

Authors:  Mark P Peterson; Kimberly A Rosvall; Charlene A Taylor; Jacqueline Ann Lopez; Jeong-Hyeon Choi; Charles Ziegenfus; Haixu Tang; John K Colbourne; Ellen D Ketterson
Journal:  J Exp Biol       Date:  2013-11-06       Impact factor: 3.312

4.  ZRANB2 localizes to supraspliceosomes and influences the alternative splicing of multiple genes in the transcriptome.

Authors:  Yee Hwa J Yang; M Andrea Markus; A Helena Mangs; Oleg Raitskin; Ruth Sperling; Brian J Morris
Journal:  Mol Biol Rep       Date:  2013-05-11       Impact factor: 2.316

Review 5.  The Supraspliceosome - A Multi-Task Machine for Regulated Pre-mRNA Processing in the Cell Nucleus.

Authors:  Kinneret Shefer; Joseph Sperling; Ruth Sperling
Journal:  Comput Struct Biotechnol J       Date:  2014-09-28       Impact factor: 7.271

6.  Supraspliceosomes at defined functional states portray the pre-assembled nature of the pre-mRNA processing machine in the cell nucleus.

Authors:  Hani Kotzer-Nevo; Flavia de Lima Alves; Juri Rappsilber; Joseph Sperling; Ruth Sperling
Journal:  Int J Mol Sci       Date:  2014-06-30       Impact factor: 5.923

7.  Palmitate- and C6 ceramide-induced Tnnt3 pre-mRNA alternative splicing occurs in a PP2A dependent manner.

Authors:  Adam J Black; Rudolf J Schilder; Scot R Kimball
Journal:  Nutr Metab (Lond)       Date:  2018-12-17       Impact factor: 4.169

8.  Pyrvinium pamoate changes alternative splicing of the serotonin receptor 2C by influencing its RNA structure.

Authors:  Manli Shen; Stanislav Bellaousov; Michael Hiller; Pierre de La Grange; Trevor P Creamer; Orit Malina; Ruth Sperling; David H Mathews; Peter Stoilov; Stefan Stamm
Journal:  Nucleic Acids Res       Date:  2013-02-07       Impact factor: 16.971

9.  SRSF5 regulates alternative splicing of DMTF1 pre-mRNA through modulating SF1 binding.

Authors:  Jialiang Li; Guangyue Li; Yige Qi; Yao Lu; Hao Wang; Ke Shi; Dangdang Li; Jinming Shi; Daniel B Stovall; Guangchao Sui
Journal:  RNA Biol       Date:  2021-07-22       Impact factor: 4.766

10.  Interplay between pre-mRNA splicing and microRNA biogenesis within the supraspliceosome.

Authors:  Lily Agranat-Tamir; Noam Shomron; Joseph Sperling; Ruth Sperling
Journal:  Nucleic Acids Res       Date:  2014-01-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.